l.salinas
TL2 Moderator · Lublin
Contributes reviews on supplier material. Based in Lublin.
Joined 30 March 2025 · last posted 3h
86 posts, newest first. Showing up to 150.
-
Coming back to: Batch date after test date, and other internal inconsistencies Replied, post #28 · Analytics › COA interpretation · 28 Jul 2026 · 1 like Coming back to post #26, because the follow-up matters more than the original answer. When a document puts the specification in the result column, it has told you the…
-
[2026 update] Correlation in a self-tracked dataset: what it can support Replied, post #3 · Research Methods › Statistics · 28 Jul 2026 · 4 likes Picking up post #2: that is the part I would want checked first. Number needed to treat: how many people need to be treated to prevent one bad outcome or achieve one…
-
Follow-up: Prior authorisation: what the criteria usually require Replied, post #97 · Access › Insurance & coverage · 26 Jul 2026 · 16 likes post #96 is right about the mechanism and I think understates the practical bit. Denial letters: the stated reason tells you exactly what to submit next. A denial is…
-
Priming a pen and whether the primed volume is wasted Replied, post #20 · Devices › Pens & autoinjectors · 23 Jul 2026 · 9 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
How shortages have affected compounding permissions Replied, post #61 · Access › Shortages · 23 Jul 2026 · 26 likes Communication from suppliers: a supplier having supply problems usually communicates them. If a supplier goes silent, that is itself information.
-
Immortal time bias in a claims-database study — one year on Replied, post #20 · Evidence › Study critique · 13 Jul 2026 · 0 likes What makes a methodological criticism substantive: it identifies a specific feature of the design that materially affects what the paper can conclude. "Small sample…
-
BPC-157: what the rodent literature actually shows, and what it does not — does this… Replied, post #5 · Compounds › Repair & healing peptides · 12 Jul 2026 · 12 likes I read post #3 twice before replying, because I had assumed the opposite. Why plausible mechanism is not evidence of effect: a mechanism that is chemically or…
-
Submitting a sample: the process end to end Replied, post #64 · Sourcing › Independent verification · 7 Jul 2026 · 4 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Tracking a shortage from primary sources rather than rumour — the long version Replied, post #2 · Access › Shortages · 5 Jul 2026 · 5 likes I read the opening post twice before replying, because I had assumed the opposite. Allocation and rationing: during severe shortages, suppliers might ration allocation…
-
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #10 · Analytics › HPLC & UHPLC · 3 Jul 2026 · 2 likes Picking up post #7: that is the part I would want checked first. Detection wavelength: 214 nm detects the peptide bond and is relatively insensitive to composition. 280…
-
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #18 · Compounds › Retatrutide · 26 Jun 2026 · 28 likes Picking up post #15: that is the part I would want checked first. Why this subcategory is more cautious than elsewhere: retatrutide is investigational, phase 3 is…
-
A checklist for reading a certificate in under two minutes Replied, post #39 · Analytics › COA interpretation · 12 Jun 2026 · 2 likes post #38 is right about the mechanism and I think understates the practical bit. Sterility testing is separate: chromatographic purity, mass spectrometry, and endotoxin…
-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #70 · Devices › Syringes & needles · 12 Jun 2026 · 1 like This follows post #67 rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add…
-
Racemisation and why it is invisible to a mass measurement Replied, post #12 · Analytics › Impurities & related substances · 8 Jun 2026 · 9 likes This follows post #9 rather than contradicting it. Incomplete deprotection: mass higher by the protecting group mass. Usually markedly later eluting. A synthesis…
-
What a certificate commits its issuer to — one year on Replied, post #83 · Analytics › COA interpretation · 6 Jun 2026 · 0 likes This follows post #80 rather than contradicting it. Endotoxin testing is separate: a certificate of purity says nothing about endotoxin. A chemically pure preparation…
-
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #81 · Sourcing › Red flags · 6 Jun 2026 · 31 likes Coming back to post #79, because the follow-up matters more than the original answer. Safety documentation absent: a supplier that cannot provide information about…
-
An appeal that succeeded, with the letter structure — the long version Replied, post #51 · Access › Insurance & coverage · 4 Jun 2026 · 5 likes Prior authorisation: pre-approval requirements and how to satisfy them. Most denials cite specific criteria. Understanding the criterion is the first step in satisfying…
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #39 · Practice › Storage & stability · 4 Jun 2026 · 5 likes Freeze-thaw: some peptide solutions tolerate freezing poorly because ice crystals damage protein structure. Whether your specific solution tolerates it depends on the…
-
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #33 · Compounds › Repair & healing peptides · 29 May 2026 · 3 likes Coming back to post #31, because the follow-up matters more than the original answer. Reading a preclinical wound-healing model: the model shows whether a mechanism is…
-
Bariatric surgery history: altered anatomy, altered expectations Replied, post #21 · Clinical › Special populations · 23 May 2026 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Trust level 3 requirements: a clarification — does this still hold? Replied, post #47 · Meta › Announcements · 15 May 2026 · 0 likes Scheduled maintenance: if the site is going offline for maintenance, advance notice will be posted here with the duration and scope.
-
Micro-titration: a disputed topic, argued properly Replied, post #73 · Practice › Dosing & titration · 12 May 2026 · 0 likes Titrating on tolerability rather than on the calendar: some people escalate when they tolerate a dose well, others escalate on the prescribed schedule regardless. The…
-
Labelling requirements for research chemicals — the long version Started this topic · Sourcing › Regulatory · 10 May 2026 · 29 likes Posting this under the heading it deserves: Labelling requirements for research chemicals — the long version Everything below is what sits behind that. I would like to…
-
Tracking a shortage from primary sources rather than rumour Replied, post #4 · Access › Shortages · 9 May 2026 · 9 likes Compounding during shortages: some jurisdictions allow pharmacy compounding when a marketed product is in shortage. That permission is jurisdiction-specific and…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — does this still hold? Replied, post #10 · Sourcing › Independent verification · 5 May 2026 · 23 likes I read post #8 twice before replying, because I had assumed the opposite. When results are inconclusive: if a testing service reports "insufficient to verify" on a…
-
Prescription portability between countries Replied, post #16 · Access › International · 25 Apr 2026 · 2 likes I read post #14 twice before replying, because I had assumed the opposite. Travel with medication: carrying a compound across borders is complicated by legal status.…
-
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #44 · Devices › Syringes & needles · 19 Apr 2026 · 0 likes Worth separating two things that post #40 runs together. Syringe barrel size: common sizes are 0.3 mL, 0.5 mL, and 1.0 mL. Smaller barrels are more legible for small…
-
Pregnancy and pregnancy planning: contraindication and washout Replied, post #116 · Clinical › Special populations · 19 Apr 2026 · 8 likes Hypoglycemia risk: in people already on insulin or sulfonylureas, adding a GLP-1 agonist requires insulin dose reduction and close monitoring for hypoglycemia. This is…
-
Blinding yourself: practical methods and their limits Replied, post #19 · Research Methods › N-of-1 designs · 19 Apr 2026 · 20 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
CJC-1295 with and without DAC: what the modification does Replied, post #36 · Compounds › Secretagogues & GH axis · 18 Apr 2026 · 27 likes Picking up post #33: that is the part I would want checked first. Pulsatile secretion matters because growth hormone is secreted in pulses, not continuously. A single…
-
Bioimpedance and hydration: why the number moves Replied, post #26 · Outcomes › Body composition · 4 Apr 2026 · 11 likes Picking up post #23: that is the part I would want checked first. Changes during titration: measuring body composition during active titration is less useful than…
-
Ultrasound and skinfolds: operator dependence in practice — what changed since Replied, post #31 · Outcomes › Body composition · 3 Apr 2026 · 17 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Journal club: is percentage weight change the right endpoint? Replied, post #16 · Evidence › Journal club · 26 Mar 2026 · 7 likes On post #12 — agreed on the reasoning, with one qualification. TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it has…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Started this topic · Practice › Reconstitution · 25 Mar 2026 · 34 likes A 5 mg vial and a 0.25 mg dose: the arithmetic in full Writing it up because I had to work it out twice and would rather nobody else did. Practical question with the…
-
The lowest dose that does anything: is that a real question? Replied, post #112 · Practice › Dosing & titration · 8 Mar 2026 · 0 likes The arithmetic of an intermediate dose: if the label says 1.0 mg and 2.0 mg, a dose strictly between them is off-label by definition. Some people compute it anyway. The…
-
Splitting a weekly dose in two: the pharmacokinetic argument against Replied, post #14 · Practice › Dosing & titration · 7 Mar 2026 · 27 likes When a dose reduction is the correct response to a side effect: if a side effect is dose-dependent (nausea, constipation, injection discomfort), reducing the dose is a…
-
Anaesthesia and elective surgery: the aspiration question Replied, post #36 · Practice › Interactions · 1 Mar 2026 · 27 likes Oral medications versus time: if you take an oral medication 30 minutes before semaglutide (which slows gastric emptying), the delayed stomach emptying affects when and…
-
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #45 · Analytics › Mass spectrometry · 22 Feb 2026 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Type 2 diabetes and the largest part of the evidence base Replied, post #9 · Clinical › Comorbidities · 20 Feb 2026 · 0 likes post #8 answers the question as asked. The question underneath it is different. PCOS and metabolic overlap: polycystic ovary syndrome has metabolic overlap with obesity…
-
Amylin receptor signalling and satiety — what changed since Replied, post #30 · Pharmacology › Receptor biology · 14 Feb 2026 · 6 likes Long-term receptor changes: very little is known about what happens to receptor expression, signalling, and downstream effects over years of exposure to these…
-
Managing an unplanned gap in supply Replied, post #16 · Access › Shortages · 28 Jan 2026 · 10 likes I read post #14 twice before replying, because I had assumed the opposite. Supply interruptions: official shortage notices are published by regulatory agencies. That is…
-
A history of disordered eating: proceeding carefully Replied, post #59 · Wellbeing › Mental health · 13 Jan 2026 · 32 likes Support and community: some people process weight change through community (online or in-person). Others prefer privacy. Knowing what you need and seeking it…
-
Second pass at: Circumference measurements as a poor man's composition estimate Replied, post #36 · Outcomes › Body composition · 6 Jan 2026 · 6 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
DXA precision and the least significant change for lean mass Replied, post #85 · Outcomes › Body composition · 19 Dec 2025 · 16 likes Ultrasound: thickness of subcutaneous fat at specific sites. Less standardised than DXA and operator-dependent. Useful as a supplementary measure but not as a primary…
-
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #22 · Clinical › Bloodwork · 4 Dec 2025 · 5 likes Liver enzymes: elevation does not specify cause. ALT and AST can rise from many things. Bilirubin helps narrow down the cause. Multiple markers together are more…
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #2 · Access › International · 4 Dec 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
A parcel stationary at a customs facility for nine days Replied, post #8 · Sourcing › Logistics · 28 Nov 2025 · 0 likes On post #4 — agreed on the reasoning, with one qualification. Import restrictions by jurisdiction: what is legal to import for personal use varies enormously by…
-
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #25 · Practice › Storage & stability · 19 Nov 2025 · 18 likes Coming back to post #23, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
-
A comparison of home results against a laboratory result on the same vial Replied, post #57 · Analytics › Home & field testing · 1 Nov 2025 · 8 likes What physical quantity does the device measure? A colorimetric or lateral-flow method typically responds to a class of chemistry rather than to a specific molecule. It…
-
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #77 · Sourcing › Vendor reports · 21 Oct 2025 · 11 likes What "verified" means on our pages: specific lots were independently measured on stated dates by named services and results were consistent with the supplier's…
-
A 40-week log with the measurement method stated Replied, post #39 · Outcomes › Progress reports · 20 Oct 2025 · 0 likes Coming back to post #37, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
-
Meeting a protein target on a suppressed appetite Replied, post #25 · Nutrition & Training › Protein & intake · 1 Oct 2025 · 8 likes Protein supplements: whey, casein, and plant-based protein powders can help hit targets when whole-food intake is limited by appetite. Protein quality (all essential…
-
Hypertension improvement and when medication needs revisiting Replied, post #53 · Clinical › Comorbidities · 11 Sep 2025 · 6 likes Chronic kidney disease: compounds in this class have renal benefit in people with kidney disease. The benefit appears to be additive to other renal-protective agents,…
-
Titles that describe the question, not the situation Replied, post #93 · Start Here › How to Ask · 11 Sep 2025 · 24 likes Asking a follow-up: new topic or reply in the old one? If the answer depends on the previous post, reply. If it is a question that makes sense without the previous…
-
Tirzepatide molecular mass and the charge states you would expect on ESI Replied, post #32 · Compounds › Tirzepatide · 29 Aug 2025 · 32 likes Storage and stability: published data on licensed tirzepatide formulations exists and is worth reading directly rather than through summarised claims. Reconstituted…
-
Coming back to: Oxidation and deamidation mass shifts, tabulated Replied, post #27 · Analytics › Mass spectrometry · 10 Aug 2025 · 2 likes Worth separating two things that post #23 runs together. Tandem mass spectrometry: MS/MS fragments the molecular ion and uses fragment masses to confirm identity and…
-
Freeze-thaw and why one cycle is not the same as five — a second dataset Replied, post #18 · Practice › Storage & stability · 2 Aug 2025 · 9 likes Protecting from light: amber vials or opaque containers reduce light exposure. If you are storing for long periods and light matters, this is worth doing. For…
-
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #93 · Compounds › Tirzepatide · 24 Jul 2025 · 2 likes post #92 is right about the mechanism and I think understates the practical bit. Nausea profile: some people report tirzepatide as less nausea-prone than semaglutide,…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #148 · Devices › Cold chain · 23 Jul 2025 · 5 likes Assessing an excursion: if a package sat at room temperature for a time, visual inspection (cloudiness, discoloration, particles) can alert you to problems. Not visible…
-
Are there stupid questions here? A staff answer, at length Started this topic · Start Here › Welcome · 19 Jul 2025 · 24 likes Are there stupid questions here? A staff answer, at length I have a specific reason for asking rather than idle curiosity, and the context is below. Question in the…
-
A field-by-field walk through a certificate of analysis Replied, post #100 · Analytics › COA interpretation · 17 Jul 2025 · 23 likes Reading old certificates: if a certificate is dated years ago, the lot it describes might be old. That is not automatically a problem but it is worth noting. Fresh…
-
A supplier that answers analytical questions with restated claims Replied, post #112 · Sourcing › Red flags · 6 Jul 2025 · 2 likes On post #108 — agreed on the reasoning, with one qualification. Exaggerated claims without documentation: every compound has limits. No peptide is "100% pure" because…
-
Sequence verification for an obscure compound: how it is done Replied, post #83 · Compounds › Other compounds · 5 Jul 2025 · 11 likes Why catalogue breadth is not evidence of anything: a supplier listing 500 compounds does not make the 450 untested ones likely to work. It makes them untested compounds…
-
Sodium, potassium and magnesium when intake drops Replied, post #39 · Nutrition & Training › Hydration & electrolytes · 1 Jul 2025 · 0 likes Coming back to post #37, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #117 · Compounds › Cagrilintide & amylin analogues · 16 Jun 2025 · 0 likes The CagriSema phase 2 paper: a fixed combination of the two components in one weekly injection. The trade-off of a fixed combination is that you cannot titrate the…
-
A claim built entirely on a subgroup analysis Replied, post #78 · Evidence › Study critique · 6 Jun 2025 · 5 likes Worth separating two things that post #74 runs together. When you change your mind: if a reply convinces you that your criticism was not well-founded, say so plainly.…
-
Second pass at: Pen dose counters: what a click does and does not guarantee Replied, post #44 · Devices › Pens & autoinjectors · 19 May 2025 · 0 likes Dose counters: pens show the remaining number of doses. When the counter reaches zero, the pen is empty and cannot deliver more. Noting the counter before injection…
-
A report I filed that turned out to be wrong, and the correction Replied, post #57 · Sourcing › Vendor reports · 17 May 2025 · 4 likes Testing service selection: Janoshik gives purity with chromatogram. Medutest gives combined purity and identity. PeptideMeter gives verification records as well as…
-
Dizziness on standing: the ordinary explanation first Replied, post #24 · Nutrition & Training › Hydration & electrolytes · 29 Apr 2025 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Reading a chromatogram someone posted without axes Replied, post #26 · Analytics › HPLC & UHPLC · 27 Apr 2025 · 0 likes Peak purity: a diode-array detector records a spectrum at every time point. If a peak contains two co-eluting species with different spectra, the spectrum changes…
-
Adducts: sodium, potassium, and the peak you did not expect Replied, post #68 · Analytics › Mass spectrometry · 15 Apr 2025 · 26 likes This follows post #65 rather than contradicting it. Calibration matters: a high-resolution instrument out of calibration can report mass with ppm error large enough to…
-
Reading order for a first week here, and what to skip until later Replied, post #62 · Start Here › Welcome · 1 Apr 2025 · 4 likes The FAQ link in the sidebar is maintained and worth ten hours of forum browsing. It is not comprehensive but it is well indexed for the questions that come up most.
-
Follow-up: Open-label extensions: what survives and what does not Replied, post #14 · Evidence › Trials · 19 Mar 2025 · 3 likes The estimand: what the trial set out to estimate. Two trials can be identical in structure but estimate different things by using different handling rules for people…
-
Second pass at: Pharmacy supply in the UK and the questions you will be asked Replied, post #22 · Regional › UK & Ireland · 12 Mar 2025 · 0 likes post #21 is right about the mechanism and I think understates the practical bit. NHS access has been restricted by commissioning criteria, not by licensing. Specialist…
-
Holding a dose indefinitely: is there a documented downside? Replied, post #13 · Practice › Dosing & titration · 12 Mar 2025 · 16 likes Worth separating two things that post #9 runs together. Holding a dose indefinitely: the trials did not study indefinite holding at a non-maximum dose. The trials…
-
Validating a method you did not develop — does this still hold? Replied, post #71 · Analytics › Method validation · 4 Mar 2025 · 24 likes Range: the concentration range over which the method has been validated. Going outside the validated range is going outside the method's demonstrated performance.
-
Preservatives: function, testing, and limits Replied, post #10 · Pharmacology › Formulation chemistry · 13 Feb 2025 · 0 likes Emulsification and suspensions: some formulations are emulsions or suspensions rather than solutions. Semaglutide formulations are solutions; some other compounds are…
-
Distinguishing a deletion sequence by mass alone Replied, post #2 · Analytics › Mass spectrometry · 18 Jan 2025 · 0 likes Mass accuracy is expressed in parts per million. It is the difference between observed and theoretical mass divided by theoretical mass, multiplied by a million. A…
-
Building a sensible monitoring schedule with your prescriber Replied, post #88 · Clinical › Bloodwork · 22 Dec 2024 · 4 likes Picking up post #85: that is the part I would want checked first. Analytical imprecision: any measurement has an error margin. A small difference in consecutive tests…
-
What changed in 2026, by region Replied, post #15 · Access › International · 9 Dec 2024 · 1 like Coming back to post #13, because the follow-up matters more than the original answer. Country-by-country legality: compound approval and legal status differ…
-
Coming back to: Research-use-only labelling: what it means and what it does not Replied, post #37 · Sourcing › Regulatory · 24 Nov 2024 · 7 likes Picking up post #34: that is the part I would want checked first. Labelling and intended use: a compound sold as "research-use-only" does not change its pharmacology if…
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #43 · Compounds › Repair & healing peptides · 13 Nov 2024 · 3 likes post #42 answers the question as asked. The question underneath it is different. Publication patterns in the BPC-157 literature: a large proportion of the evidence…
-
Reporting a discrepancy without making an allegation Replied, post #51 · Sourcing › Vendor reports · 31 Aug 2024 · 0 likes Disputed records: when a result disagreed and was not explained, the record says disputed and stays that way. We do not remove inconvenient history; we document it.
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #18 · Analytics › COA interpretation · 2 Aug 2024 · 10 likes When a document puts the specification in the result column, it has told you the release criterion, not the measurement. Those are different claims and the second is…
-
How this community labels and discusses unrefereed work Replied, post #108 · Evidence › Preprints · 24 Jul 2024 · 30 likes Picking up post #105: that is the part I would want checked first. Do not build anything on a preprint that you would mind rebuilding: if the preprint later changes…
-
Why our vendor pages link the storefront and mark it sponsored Replied, post #3 · Sourcing › Vendor reports · 23 Jul 2024 · 5 likes Testing service selection: Janoshik gives purity with chromatogram. Medutest gives combined purity and identity. PeptideMeter gives verification records as well as…